Effects of SLC22A2 808G>T polymorphism and bosutinib concentrations on serum creatinine in patients with chronic myeloid leukemia receiving bosutinib therapy

Abumiya, M; Takahashi, N; Takahashi, S; Yoshioka, T; Kameoka, Y; Miura, M

Miura, M (corresponding author), Akita Univ Hosp, Dept Pharm, 1-1-1 Hondo, Akita 0108543, Japan.

SCIENTIFIC REPORTS, 2021; 11 (1):

Abstract

The purpose of this study was to investigate the effects of SLC22A2 808G>T polymorphism and trough concentrations (C-0) of bosutinib on serum creat......

Full Text Link